Chronic respiratory conditions becoming more prevalent is the major factor driving the growth of the MEA asthma spacers market. Asthma causes swellings in airways passages, narrowing airways to the lungs and further causing trouble breathing, tightness in the chest, wheezing, and other associated indications. Chronic obstructive pulmonary disease (COPD) also causes obstructions in airflow. The causes of these conditions are unclear; however, genetic factors, environmental conditions, overweight conditions, and smoking are major risk factors.
Government authorities and healthcare institutions are implementing various programs to increase asthma awareness and prevent disease morbidity. The National Asthma Control Program (NACP), launched by the Centers for Disease Control and Prevention, is working continually to increase awareness regarding asthma and curb the disease. The program is dedicated to conducting asthma surveillance and research to deal with the disease. Such programs are boosting the adoption of inhalers, which are, in turn, driving the market. Also, the MEA region is experiencing decent growth in the number of industries, including medical, demanding advanced products and solutions. This factor boosts the asthma spacers market in the region. Also, the steady growth in the levels of pollution coupled with constantly changing lifestyles in the region. Moreover, the growing prevalence of respiratory disorders also creates a huge demand for the region's asthma spacers market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA asthma spacers market. The MEA asthma spacers market is expected to grow at a good CAGR during the forecast period.
MEA Asthma Spacers Market Segmentation
The MEA asthma spacers market is segmented into product, distribution channel, and country. Based on product, the MEA asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the MEA asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the MEA asthma spacers market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the MEA. The rest of the MEA held the largest market share in 2022.
Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Lupin, Metall Zug, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.